Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis.
BACKGROUND
Combinatorial phage display has been used in the last 20 years in the identification of protein-ligands and protein-protein interactions, uncovering relevant molecular recognition events. Rate-limiting steps of combinatorial phage display library selection are (i) the counting of transducing units and (ii) the sequencing of the encoded displayed ligands. Here, we adapted emerging genomic technologies to minimize such challenges.


RESULTS
We gained efficiency by applying in tandem real-time PCR for rapid quantification to enable bacteria-free phage display library screening, and added phage DNA next-generation sequencing for large-scale ligand analysis, reporting a fully integrated set of high-throughput quantitative and analytical tools. The approach is far less labor-intensive and allows rigorous quantification; for medical applications, including selections in patients, it also represents an advance for quantitative distribution analysis and ligand identification of hundreds of thousands of targeted particles from patient-derived biopsy or autopsy in a longer timeframe post library administration. Additional advantages over current methods include increased sensitivity, less variability, enhanced linearity, scalability, and accuracy at much lower cost. Sequences obtained by qPhage plus pyrosequencing were similar to a dataset produced from conventional Sanger-sequenced transducing-units (TU), with no biases due to GC content, codon usage, and amino acid or peptide frequency. These tools allow phage display selection and ligand analysis at >1,000-fold faster rate, and reduce costs approximately 250-fold for generating 10(6) ligand sequences.


CONCLUSIONS
Our analyses demonstrates that whereas this approach correlates with the traditional colony-counting, it is also capable of a much larger sampling, allowing a faster, less expensive, more accurate and consistent analysis of phage enrichment. Overall, qPhage plus pyrosequencing is superior to TU-counting plus Sanger sequencing and is proposed as the method of choice over a broad range of phage display applications in vitro, in cells, and in vivo.
Dias-Neto
Emmanuel
E
David H. Koch Center, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States of America.
Nunes
Diana N
DN
Giordano
Ricardo J
RJ
Sun
Jessica
J
Botz
Gregory H
GH
Yang
Kuan
K
Setubal
João C
JC
Pasqualini
Renata
R
Arap
Wadih
W
D001435:Bacteriophages / Q000235:genetics; D003362:Cost-Benefit Analysis; D004247:DNA / Q000235:genetics; D030561:Databases, Nucleic Acid; D057166:High-Throughput Screening Assays / Q000191:economics* / Q000379:methods*; D006801:Humans; D019151:Peptide Library; D010455:Peptides / Q000737:chemistry; D017422:Sequence Analysis, DNA; D013997:Time Factors; D014161:Transduction, Genetic; D053586:Virus Internalization
D019151:Peptide Library; D010455:Peptides; D004247:DNA